ID   MC/CAR-Z2
AC   CVCL_6671
SY   MC-CAR-Z2; MNS-2
DR   CLO; CLO_0007576
DR   ATCC; CRL-8147
DR   BioSample; SAMN03471194
DR   Cell_Model_Passport; SIDM00635
DR   Wikidata; Q54904191
RX   Patent=US4647535;
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Parent cell line (MC/CAR) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8147.
CC   Population: Caucasian.
CC   Doubling time: ~20-24 hours (ATCC=CRL-8147).
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 11,14,15
ST   D7S820: 9,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1397 ! MC/CAR
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
RX   Patent=US4647535;
RA   Ritts R.E. Jr.;
RT   "Human nonsecretory plasmacytoid cell line.";
RL   Patent number US4647535, 03-Mar-1987.
//